CN102372770A - 一种抑血管生成素、纯化方法及含有它们的药物组合物 - Google Patents
一种抑血管生成素、纯化方法及含有它们的药物组合物 Download PDFInfo
- Publication number
- CN102372770A CN102372770A CN2010102527177A CN201010252717A CN102372770A CN 102372770 A CN102372770 A CN 102372770A CN 2010102527177 A CN2010102527177 A CN 2010102527177A CN 201010252717 A CN201010252717 A CN 201010252717A CN 102372770 A CN102372770 A CN 102372770A
- Authority
- CN
- China
- Prior art keywords
- angiogenin
- presses down
- angiogenesis
- damping fluid
- inhibitant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (16)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010252717.7A CN102372770B (zh) | 2010-08-13 | 2010-08-13 | 一种抑血管生成素、纯化方法及含有它们的药物组合物 |
PCT/CN2011/001000 WO2012019423A1 (zh) | 2010-08-13 | 2011-06-16 | 抑血管生成素、其纯化方法及包含其的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010252717.7A CN102372770B (zh) | 2010-08-13 | 2010-08-13 | 一种抑血管生成素、纯化方法及含有它们的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102372770A true CN102372770A (zh) | 2012-03-14 |
CN102372770B CN102372770B (zh) | 2014-04-30 |
Family
ID=45567311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010252717.7A Active CN102372770B (zh) | 2010-08-13 | 2010-08-13 | 一种抑血管生成素、纯化方法及含有它们的药物组合物 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN102372770B (zh) |
WO (1) | WO2012019423A1 (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102847137A (zh) * | 2012-07-02 | 2013-01-02 | 兆科药业(香港)有限公司 | 抑血管生成素的药物用途 |
WO2014005241A1 (zh) * | 2012-07-02 | 2014-01-09 | 兆科药业(香港)有限公司 | 抑血管生成素的药物用途 |
CN104387499A (zh) * | 2014-08-15 | 2015-03-04 | 济南盛岳林生物工程有限公司 | 一种利用免疫亲和技术提纯硫酸软骨素的方法 |
CN113185595A (zh) * | 2020-12-11 | 2021-07-30 | 兆科(广州)眼科药物有限公司 | 一种具有抑制新生血管生长及抑制炎症反应活性的蛋白质及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1332242A (zh) * | 2001-04-29 | 2002-01-23 | 中国科学院昆明动物研究所 | 一种尖吻蝮蛇毒凝血酶及其生产方法 |
CN101190943A (zh) * | 2006-11-30 | 2008-06-04 | 首都医科大学 | 江浙腹蛇蛇毒双链肽、其制备方法及应用 |
CN101358184A (zh) * | 2008-09-27 | 2009-02-04 | 康辰医药股份有限公司 | 尖吻蝮蛇蛇毒血凝酶 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100395331C (zh) * | 2004-08-11 | 2008-06-18 | 北京赛生药业有限公司 | 高纯度蛇毒激肽原酶的制备方法及其药物制剂 |
CN100424171C (zh) * | 2004-08-16 | 2008-10-08 | 北京赛生药业有限公司 | 高纯度蛇毒纤溶酶的制备方法及其药物制剂 |
-
2010
- 2010-08-13 CN CN201010252717.7A patent/CN102372770B/zh active Active
-
2011
- 2011-06-16 WO PCT/CN2011/001000 patent/WO2012019423A1/zh active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1332242A (zh) * | 2001-04-29 | 2002-01-23 | 中国科学院昆明动物研究所 | 一种尖吻蝮蛇毒凝血酶及其生产方法 |
CN101190943A (zh) * | 2006-11-30 | 2008-06-04 | 首都医科大学 | 江浙腹蛇蛇毒双链肽、其制备方法及应用 |
CN101358184A (zh) * | 2008-09-27 | 2009-02-04 | 康辰医药股份有限公司 | 尖吻蝮蛇蛇毒血凝酶 |
CN101560510A (zh) * | 2008-09-27 | 2009-10-21 | 北京方策方程医药科技有限公司 | 尖吻蝮蛇血凝酶 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102847137A (zh) * | 2012-07-02 | 2013-01-02 | 兆科药业(香港)有限公司 | 抑血管生成素的药物用途 |
WO2014005241A1 (zh) * | 2012-07-02 | 2014-01-09 | 兆科药业(香港)有限公司 | 抑血管生成素的药物用途 |
CN104387499A (zh) * | 2014-08-15 | 2015-03-04 | 济南盛岳林生物工程有限公司 | 一种利用免疫亲和技术提纯硫酸软骨素的方法 |
CN113185595A (zh) * | 2020-12-11 | 2021-07-30 | 兆科(广州)眼科药物有限公司 | 一种具有抑制新生血管生长及抑制炎症反应活性的蛋白质及其制备方法 |
WO2022121084A1 (zh) * | 2020-12-11 | 2022-06-16 | 兆科(广州)眼科药物有限公司 | 一种具有抑制新生血管生长及抑制炎症反应活性的蛋白质及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102372770B (zh) | 2014-04-30 |
WO2012019423A1 (zh) | 2012-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100558367C (zh) | 化合物在制备用于提高癌症治疗疗效的药物中的用途 | |
CN101838323B (zh) | 一种抗血小板溶栓素及其制备方法 | |
US4801578A (en) | Muramylpeptide-glycoprotein immunostimulant derivatives, their preparation and their use in medication | |
CN101967192B (zh) | 抗cd20抗体片段与力达霉素的融合蛋白、制备方法及其用途 | |
Ono et al. | Inhibition of tumor growth and neovascularization by an anti-gastric ulcer agent, irsogladine | |
CN102372770B (zh) | 一种抑血管生成素、纯化方法及含有它们的药物组合物 | |
CN104906576B (zh) | 可供皮下注射的高浓度抗vegf抗体配制剂 | |
CN103524628B (zh) | 重组灵芝免疫调节蛋白与人血清白蛋白融合蛋白及其制备方法与应用 | |
CN107760661A (zh) | 药用激肽原酶的peg修饰物及其制备方法和应用 | |
CN110448681B (zh) | 一种用于恶性肿瘤免疫治疗的联合药物 | |
CN101070350B (zh) | 针对cd13的靶向肽与力达霉素构成的强化融合蛋白ngr-ldp-ae | |
CN108642070A (zh) | 特异性诱导肿瘤细胞凋亡的重组人Fc抗体及其制备方法、用途 | |
CN106029683A (zh) | 一种抑制肿瘤转移和治疗白血病的多肽和多肽复合物、其制备方法及其应用 | |
CN110483647B (zh) | 一种抗肿瘤多肽及其应用 | |
CN102453097A (zh) | 抑制血管新生的融合蛋白vf及药物组合物和应用 | |
CN103880963A (zh) | 半乳糖凝集素-3C(Galectin-3C) 抗体融合蛋白的制备方法和用途 | |
CN102680272B (zh) | 一种海胆多糖的提取、纯化及鉴定方法 | |
CN101781369A (zh) | 一种重组人精氨酸酶融合蛋白及其应用 | |
CN101224297A (zh) | 重组人血管内皮抑制素在制药中的应用 | |
CA2832376A1 (en) | Drug containing recombinant mistletoe lectins for treating malignant melanoma | |
CN103304669A (zh) | 人源化肿瘤免疫细胞因子tntil2及其制备方法和用途 | |
CN107058269A (zh) | 药用激肽原酶及其制备方法和应用 | |
CN102770452B (zh) | 一种PA-MSHA菌株IgY及其制备方法和应用 | |
CN1110322C (zh) | 单克隆抗体Fab'-平阳霉素偶联物及其抗肿瘤作用 | |
CN104961831A (zh) | 一种修饰的重组人内皮抑素及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHAOKE PHARMACEUTICAL (GUANGZHOU) CO., LTD. Free format text: FORMER OWNER: ZHAOKE PHARMACEUTICAL (HK) CO., LTD. Effective date: 20120820 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: HONG KONG, CHINA TO: 511400 GUANGZHOU, GUANGDONG PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120820 Address after: 511400 Guangdong city of Guangzhou province Nansha District Jinling Road No. 93 Bank of China Tower, room 440 Applicant after: ZHAOKE PHARMACEUTICAL (HONGKONG) CO., LTD. Address before: Room 110-111, bioinformatics centre, two West science Avenue, Sha Tin Hongkong Science Park, Hongkong, China Applicant before: Zhaoke Pharmaceutical (Hongkong) Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190313 Address after: 511466 Room 501, 5th Floor, Area A, No. 1 Meide No. 3 Road, Pearl River Industrial Park, Nansha District, Guangzhou City, Guangdong Province (Office only) Patentee after: Mega eye (Guangzhou) ophthalmic drug Co., Ltd. Address before: 511400 Room 440, Zhongyin Building, 93 Jinling North Road, Nansha District, Guangzhou City, Guangdong Province Patentee before: ZHAOKE PHARMACEUTICAL (HONGKONG) CO., LTD. |
|
TR01 | Transfer of patent right |